Inflammation Program

About Bessor Pharma

Bessor Pharma is a privately held, pre-revenue biotech company leveraging a dual-strategy of therapeutic and platform development. Its core focus is on advancing novel small molecule programs in immuno-oncology and inflammation, while simultaneously building a proprietary biomimetic chemical synthesis platform to access a new class of natural product-like compounds. The company's model involves de-risking projects internally before seeking partnerships, supported by a leadership team with deep industry experience in drug development, chemistry, and business strategy.

Therapeutic Areas